
Cov duab zaum kawg Distinguishing kev koom tes los ntawm Shares Tendered
PolyPeptide tau hais tias 97.99% kev koom tes tus nqi sawv cev rau 32,458,892 shares nyob rau hauv aggregate, combining shares validly tendered nrog shares twb tuav los ntawm Samsung Peptide thiab ob tog ua yeeb yam nrog nws. Los ntawm kev kaw lub sijhawm ntxiv kev lees paub rau lub Kaum Hlis 30, cov tswv lag luam tau lees paub kev sib tw 32,350,302 shares. Cov shares sawv cev rau 97.98% ntawm cov shares them los ntawm qhov muab thiab 97.66% ntawm PolyPeptide tag nrho cov peev txheej thiab cov cai pov npav. Qhov sib txawv ntawm peb feem pua hais txog qhov sib koom ntawm txhua qhov kev suav suav thiab qhov sib koom ua ke tiv thaiv qhov lawv ntsuas.
Nyiaj Pov Hwm Tus Nqi PolyPeptide ntawm kwv yees li CHF 1.46 Billion
Samsung Biologics tshaj tawm qhov kev thov yuav tau nyob rau hauv Lub Xya Hli ntawm CHF 44.31 ib feem ntawm cov nyiaj ntsuab, muaj nuj nqis ntawm PolyPeptide cov nyiaj tau los tag nrho ntawm kwv yees li CHF 1.46 billion, tsis suav nrog cov nyiaj khaws cia. Samsung Peptide AG, lub tuam txhab cov tuam txhab ncaj qha Swiss, tau tshaj tawm cov ntawv tshaj tawm thaum Lub Yim Hli 31 rau txhua qhov kev sib koom ua lag luam. Lub Kaum Ib Hlis hloov tshiab lees paub qhov kev sib tw zaum kawg suav tom qab lub sijhawm txais ntxiv. Tus nqi muab nyiaj ntsuab thiab tus nqi sib npaug piav qhia txog cov nqe lus ntawm kev sib pauv, thaum tus nqi koom nrog sau cov ntaub ntawv sib sau ua ke qhia thaum kaw qhov kev thov.


Kev Txiav Txim Txiaj Ntsig Tshaj Li Lub Kaum Ib Hlis Ntuj
Daim ntawv tshaj tawm tau qhia lub Kaum Ib Hlis 13, 2026, raws li hnub sib tham. Samsung ncua hnub ntawd tom qab tshuaj xyuas cov xwm txheej ntawm cov txheej txheem kev pom zoo hauv ntau txoj cai. Nws lub Kaum Ib Hlis 5 hloov tshiab tau tso cia kom tiav mus rau qhov kawg ntawm 2026 lossis hauv thawj peb lub hlis twg ntawm 2027. Samsung tau hais tias nws yuav tshaj tawm hnub sib tham tshwj xeeb thaum txhua qhov kev thov tau ua tiav. Tom qab kev sib hais haum, Samsung Peptide npaj siab mus nrhiav kev nyem tawm ntawm cov tswv lag luam uas tseem tshuav thiab thov kom tshem tawm PolyPeptide cov koom nrog los ntawm SIX Swiss Exchange.
Kev yuav khoom yuav nthuav dav Samsung's Peptide Manufacturing Capabilities
PolyPeptide muab kev cog lus tsim kho thiab tsim cov kev pabcuam rau peptide-based active tshuaj cov khoom xyaw. Samsung Biologics tau hais txog lub tuam txhab Swiss cov kws tshaj lij peptide thiab thoob ntiaj teb kev tsim khoom lag luam vim li cas thiaj li tau txais. Qhov kev sib koom ua ke yuav ntxiv cov peev txheej no rau Samsung daim ntawv cog lus tsim khoom lag luam thiab nthuav dav ntau yam ntawm cov tshuaj yeeb tshuaj uas nws tuaj yeem txhawb nqa. Cov txiaj ntsig kev sib tw tseeb txiav txim siab pes tsawg feem tau xa tuaj raws li qhov kev thov. Lub sijhawm tseem ceeb tom ntej rau ob lub tuam txhab thiab rau cov neeg siv khoom tom qab qhov kev sib pauv yog kev pom zoo ntawm hnub sib tham.


